Cataract operation adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From February 2004 to June 2026, FDA received 5,835 adverse event reports that record the MedDRA preferred term Cataract operation. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 379 reports in the 12 months to June 2026 and 423 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,130 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 379 (under 0.1%) record this term. Reports for patients aged 65 to 74 were 23.3% of the reports that record this term and 11.3% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 125 drug pages with 10 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Cataract operation name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	89
Actemra	Interleukin-6 receptor antagonist	61
Actonel	Bisphosphonate	30
Advair Diskus	Corticosteroid	88
Advair Diskus 100/50		10
Advair Hfa	Corticosteroid	68
Aimovig		13
Albuterol sulfate	beta2-Adrenergic agonist	29
Alendronate sodium	Bisphosphonate	224
Alpha -Tocopherol D-		26
Altace		24
Anoro Ellipta	Anticholinergic	22
Apixaban	Factor Xa inhibitor	11
Arava	Antirheumatic agent	37
Aubagio	Pyrimidine synthesis inhibitor	17
Avastin	Vascular endothelial growth factor inhibitor	12
Avonex	Interferon beta	22
Benlysta	B lymphocyte stimulator-specific inhibitor	14
Bimekizumab		19
Boniva		34
Breo Ellipta	Corticosteroid	47
Byetta	GLP-1 receptor agonist	33
Celebrex	Nonsteroidal anti-inflammatory drug	25
Certolizumab pegol	Tumor necrosis factor blocker	72
Chantix	Partial cholinergic nicotinic agonist	11
Cimzia	Tumor necrosis factor blocker	62
Corticotropin		13
Cosopt	Carbonic anhydrase inhibitor	11
Crestor	HMG-CoA reductase inhibitor	18
Cyclosporine	Calcineurin inhibitor immunosuppressant	33
Desoximetasone	Corticosteroid	31
Digoxin	Cardiac glycoside	19
Diovan	Angiotensin 2 receptor blocker	24
Diovan HCT	Angiotensin 2 receptor blocker	17
Dupixent	Interleukin-4 receptor alpha antagonist	122
Eliquis	Factor Xa inhibitor	29
Enbrel	Tumor necrosis factor blocker	336
Exforge	Angiotensin 2 receptor blocker	11
Eylea	Vascular endothelial growth factor inhibitor	220
Femara	Aromatase inhibitor	11
Flomax		11
Flovent	Corticosteroid	12
Fluticasone propionate and salmeterol	Corticosteroid	21
Forteo	Parathyroid hormone analog	126
Fosamax	Bisphosphonate	374
Fosamax Plus D		70
Gleevec	Kinase inhibitor	13
Gold	Standardized chemical allergen	29
Gold Sodium Thiomalate		30
Harnal		14
Hizentra	Human immunoglobulin G	11
Humalog	Insulin analog	48
Humira		105
Humulin N	Insulin	20
Humulin R	Insulin	13
Hydroxychloroquine	Antimalarial	16
Hydroxychloroquine sulfate	Antimalarial	34
Iluvien	Corticosteroid	35
Incruse Ellipta	Anticholinergic	12
Infliximab	Tumor necrosis factor blocker	11
Insulin aspart	Insulin analog	12
Insulin glargine	Insulin analog	15
Insulin human	Insulin	16
Janumet	Biguanide	19
Januvia	Dipeptidyl peptidase 4 inhibitor	55
Lacosamide		10
Lantus	Insulin analog	89
Lantus Solostar	Insulin analog	142
Latanoprost	Prostaglandin analog	13
Leflunomide	Antirheumatic agent	36
Levemir	Insulin analog	28
Lipitor	HMG-CoA reductase inhibitor	45
Lucentis	Vascular endothelial growth factor inhibitor	29
Lyrica		31
Mepolizumab	Interleukin-5 antagonist	34
Metformin	Biguanide	28
Metformin hydrochloride	Biguanide	11
Methotrexate	Folate analog metabolic inhibitor	63
Miebo		42
Mycophenolate mofetil	Antimetabolite immunosuppressant	32
Neoral	Calcineurin inhibitor immunosuppressant	30
Nexium	Proton pump inhibitor	17
Niraparib	Poly(ADP-Ribose) polymerase inhibitor	16
Novolog	Insulin analog	73
Nuplazid	Atypical antipsychotic	18
Opsumit	Endothelin receptor antagonist	40
Opticlick		16
Orencia	Selective T cell costimulation modulator	65
Orgovyx	Gonadotropin releasing hormone receptor antagonist	19
Otezla	Phosphodiesterase 4 inhibitor	18
Ozempic	GLP-1 receptor agonist	208
Plaquenil	Antimalarial	20
Prednisone	Corticosteroid	52
Pregabalin		36
Prolia	RANK ligand inhibitor	105
Rebif	Interferon beta	26
Remicade	Tumor necrosis factor blocker	69
Repatha	PCSK9 inhibitor	46
Restasis	Calcineurin inhibitor immunosuppressant	16
Rinvoq	Janus kinase inhibitor	14
Rituxan	CD20-directed cytolytic antibody	12
Rituximab	CD20-directed cytolytic antibody	53
Seroquel	Atypical antipsychotic	12
Simponi	Tumor necrosis factor blocker	30
Solostar		37
Sulfasalazine	Aminosalicylate	37
Tiotropium bromide	Anticholinergic	18
Tracleer	Endothelin receptor antagonist	41
Trelegy Ellipta	Anticholinergic	26
Tresiba	Insulin analog	58
Truxima	CD20-directed cytolytic antibody	14
Tysabri	Integrin receptor antagonist	27
Uptravi	Prostacyclin receptor agonist	25
Veletri	Prostacycline vasodilator	13
Ventolin Hfa	beta2-Adrenergic agonist	46
Viagra	Phosphodiesterase 5 inhibitor	11
Victoza	GLP-1 receptor agonist	29
Vioxx		20
Vyepti		15
Vyvgart	Neonatal Fc receptor blocker	15
Wegovy	GLP-1 receptor agonist	17
Xalatan	Prostaglandin analog	128
Xarelto	Factor Xa inhibitor	24
Xeljanz	Janus kinase inhibitor	70
Xyrem	Central nervous system depressant	17

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 38 pharmacologic classes with 25 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Cataract operation name, in order of name
Class	Reports with this term
Aminosalicylate	37
Angiotensin 2 receptor blocker	56
Anticholinergic	81
Antimalarial	70
Antimetabolite immunosuppressant	34
Antirheumatic agent	73
Atypical antipsychotic	35
beta2-Adrenergic agonist	81
Biguanide	59
Bisphosphonate	639
Calcineurin inhibitor immunosuppressant	85
CD20-directed cytolytic antibody	79
Corticosteroid	386
Dipeptidyl peptidase 4 inhibitor	55
Endothelin receptor antagonist	91
Factor Xa inhibitor	66
Folate analog metabolic inhibitor	72
GLP-1 receptor agonist	300
HMG-CoA reductase inhibitor	73
Insulin	69
Insulin analog	500
Integrin receptor antagonist	29
Interferon beta	48
Interleukin-4 receptor alpha antagonist	128
Interleukin-5 antagonist	41
Interleukin-6 receptor antagonist	61
Janus kinase inhibitor	87
Kinase inhibitor	48
Nonsteroidal anti-inflammatory drug	33
Parathyroid hormone analog	126
PCSK9 inhibitor	46
Prostacyclin receptor agonist	27
Prostaglandin analog	159
RANK ligand inhibitor	107
Selective T cell costimulation modulator	154
Standardized chemical allergen	29
Tumor necrosis factor blocker	587
Vascular endothelial growth factor inhibitor	274

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Cataract operation, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Cataract operation
Age	Reports	Share
Under 2	3	0.1%
2 to 11	6	0.1%
12 to 17	3	0.1%
18 to 44	60	1%
45 to 64	787	13.5%
65 to 74	1,359	23.3%
75 and over	1,000	17.1%
Age not given	2,617	44.9%

Sex of the patient in the reports that record Cataract operation
Sex	Reports	Share
Female	3,773	64.7%
Male	1,512	25.9%
Unknown or not given	550	9.4%

Age and sex are as the report gives them. 71.1% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Cataract operation: adverse event reports that record this term. https://reportedreactions.com/reaction/cataract-operation/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Cataract operation mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page